Neonatal Purpura Fulminans

Neonatal purpura fulminans is a rare and serious blood clotting disorder that affects newborn babies. It happens when the body forms blood clots in small blood vessels throughout the skin and other organs. These clots block normal blood flow and cause areas of skin to die, creating dark purple or black patches.

This condition is caused by a severe deficiency of Protein C, a natural substance in blood that prevents clots from forming too easily. Babies with neonatal purpura fulminans inherit two copies of a faulty gene, one from each parent. Without enough Protein C, the blood clots too much and too quickly. This leads to dangerous blockages in tiny blood vessels.

The condition appears within hours to days after birth. It requires immediate medical attention and lifelong treatment. Early recognition and treatment can prevent life-threatening complications and help babies grow into healthier children.

• Large purple or black patches on the skin that appear soon after birth
• Skin areas that look bruised or discolored, often on the limbs or buttocks
• Skin tissue that begins to die or develop open wounds
• Fever or signs of infection
• Difficulty feeding or appearing unwell
• Excessive bleeding from the umbilical cord or injection sites
• Blood clots in major organs like the eyes or brain
• Rapid breathing or other signs of distress

Most babies with this condition show symptoms within the first few days of life. The skin changes are usually the first noticeable sign. Without treatment, the condition progresses rapidly and can become life-threatening.

Neonatal purpura fulminans is caused by inheriting two abnormal copies of the gene that makes Protein C. When both parents carry one faulty gene, their baby has a 25 percent chance of getting both faulty copies. This is called homozygous Protein C deficiency. Without working Protein C, the blood cannot regulate clotting properly. The result is widespread clot formation in small blood vessels.

Risk factors include having parents who are carriers of Protein C gene mutations or having a family history of blood clotting disorders. Consanguinity, when parents are related by blood, increases the chance of inheriting two copies of the same faulty gene. In some rare cases, severe infections in newborns can trigger a similar condition even without genetic deficiency.

Doctors diagnose neonatal purpura fulminans based on the appearance of the skin and specialized blood tests. The key test measures Protein C Activity in the blood. Babies with this condition have very low or undetectable levels of Protein C. Other blood tests check clotting function and look for signs of widespread clot formation throughout the body.

Because this is a rare and specialized condition, diagnosis requires immediate attention from neonatal specialists and hematologists. Genetic testing can confirm the specific mutation causing the Protein C deficiency. Talk to a doctor about appropriate testing if you have a family history of blood clotting disorders and are planning to have children.

• Immediate replacement of Protein C through infusions of fresh frozen plasma or Protein C concentrate
• Lifelong Protein C replacement therapy to prevent new clots from forming
• Blood thinning medications like warfarin once the baby is stable
• Wound care for damaged skin areas to prevent infection
• Monitoring by a hematologist who specializes in blood disorders
• Regular blood tests to check Protein C levels and clotting function
• Preventing infections through good hygiene and prompt treatment when illness occurs
• Genetic counseling for families to understand inheritance patterns